{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:33:48Z","timestamp":1780914828019,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1245\/s10434-013-2932-7","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T11:30:52Z","timestamp":1364383852000},"page":"2607-2614","source":"Crossref","is-referenced-by-count":45,"title":["The Prognostic Value of Lymph Node Ratio in Node-Positive Breast Cancer: A Dutch Nationwide Population-Based Study"],"prefix":"10.1245","volume":"20","author":[{"given":"Pim J. M.","family":"Dings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes A. G.","family":"Elferink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc J. A.","family":"Strobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H. W.","family":"de Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"2932_CR1","unstructured":"Netherlands Cancer Registry. Dutch Cancer Figures. http:\/\/www.cancerregistry.nl . Accessed: June 19, 2012."},{"key":"2932_CR2","unstructured":"Statistics Netherlands. CBS StatLine. http:\/\/www.statline.cbs.nl\/StatWeb . Accessed: June 19, 2012."},{"key":"2932_CR3","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","volume":"20","author":"SE Singletary","year":"2002","unstructured":"Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628\u201336.","journal-title":"J Clin Oncol"},{"key":"2932_CR4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5858\/2000-124-0966-PFIBC","volume":"124","author":"PL Fitzgibbons","year":"2000","unstructured":"Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:966\u201378.","journal-title":"Arch Pathol Lab Med."},{"key":"2932_CR5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1200\/JCO.1989.7.3.355","volume":"7","author":"PR Rosen","year":"1989","unstructured":"Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol. 1989;7:355\u201366.","journal-title":"J Clin Oncol."},{"key":"2932_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567\u201375.","journal-title":"N Engl J Med."},{"key":"2932_CR7","first-page":"732","volume":"237","author":"SW Beenken","year":"2003","unstructured":"Beenken SW, Urist MM, Zhang Y, Desmond R, Krontiras H, Medina H, et al. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg. 2003;237:732\u20139.","journal-title":"Ann Surg."},{"key":"2932_CR8","volume-title":"American Joint Committee on Cancer Staging Manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer Staging Manual. 7th edition. New York: Springer; 2010.","edition":"7"},{"key":"2932_CR9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181\u20137.","journal-title":"Cancer."},{"key":"2932_CR10","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/0959-8049(92)90534-9","volume":"28A","author":"CK Axelsson","year":"1992","unstructured":"Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer. 1992;28A:1415\u20138.","journal-title":"Eur J Cancer."},{"key":"2932_CR11","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.1999.17.6.1689","volume":"17","author":"A Recht","year":"1999","unstructured":"Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, et al. Locoregional failure 10\u00a0years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689\u2013700.","journal-title":"J Clin Oncol."},{"key":"2932_CR12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1245\/ASO.2006.02.020","volume":"13","author":"M Schaapveld","year":"2006","unstructured":"Schaapveld M, de Vries EG, van der Graaf WT, Otter R, de Vries J, Willemse PH. The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association? Ann Surg Oncol. 2006;13:465\u201374.","journal-title":"Ann Surg Oncol."},{"key":"2932_CR13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jso.10198","volume":"82","author":"DW Petrik","year":"2003","unstructured":"Petrik DW, McCready DR, Sawka CA, Goel V. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. J Surg Oncol. 2003;82:84\u201390.","journal-title":"J Surg Oncol."},{"key":"2932_CR14","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1245\/s10434-008-9938-6","volume":"15","author":"T Cil","year":"2008","unstructured":"Cil T, Hauspy J, Kahn H, Melnick W, Flynn C, Holloway CM. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients. Ann Surg Oncol. 2008;15:3361\u20138.","journal-title":"Ann Surg Oncol."},{"key":"2932_CR15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/ejso.2002.1239","volume":"28","author":"BC Wal van der","year":"2002","unstructured":"van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol. 2002;28:481\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"2932_CR16","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1200\/JCO.2005.03.1526","volume":"24","author":"WA Woodward","year":"2006","unstructured":"Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006;24:2910\u20136.","journal-title":"J Clin Oncol."},{"key":"2932_CR17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1200\/JCO.2008.18.6965","volume":"27","author":"V Vinh-Hung","year":"2009","unstructured":"Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009;27:1062\u20138.","journal-title":"J Clin Oncol."},{"key":"2932_CR18","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1245\/s10434-011-2012-9","volume":"18","author":"AB Chagpar","year":"2011","unstructured":"Chagpar AB, Camp RL, Rimm DL. Lymph node ratio should be considered for incorporation into staging for breast cancer. Ann Surg Oncol. 2011;18:3143\u20138.","journal-title":"Ann Surg Oncol."},{"key":"2932_CR19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jamcollsurg.2010.02.045","volume":"210","author":"ME Danko","year":"2010","unstructured":"Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA, Jr. Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. J Am Coll Surg. 2010;210:797\u2013807.","journal-title":"J Am Coll Surg."},{"key":"2932_CR20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-011-1730-9","volume":"130","author":"SH Ahn","year":"2011","unstructured":"Ahn SH, Kim HJ, Lee JW, Gong GY, Noh DY, Yang JH, et al. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Breast Cancer Res Treat. 2011;130:507\u201315.","journal-title":"Breast Cancer Res Treat."},{"key":"2932_CR21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1634\/theoncologist.2010-0044","volume":"15","author":"V Vinh-Hung","year":"2010","unstructured":"Vinh-Hung V, Joseph SA, Coutty N, Ly BH, Vlastos G, Nguyen NP. Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer. Oncologist. 2010;15:1050\u201362.","journal-title":"Oncologist."},{"key":"2932_CR22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/SLA.0b013e31818842ec","volume":"248","author":"F Peschaud","year":"2008","unstructured":"Peschaud F, Benoist S, Julie C, Beauchet A, Penna C, Rougier P, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg. 2008;248:1067\u201373.","journal-title":"Ann Surg."},{"key":"2932_CR23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gut.2006.104117","volume":"55","author":"M Ridder De","year":"2006","unstructured":"De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, Hoorens A, Sermeus A, Storme G. Prognostic value of the lymph node ratio in node positive colon cancer. Gut. 2006;55:1681.","journal-title":"Gut."},{"key":"2932_CR24","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1245\/s10434-008-0123-8","volume":"15","author":"J Peng","year":"2008","unstructured":"Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, et al. Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol. 2008;15:3118\u201323.","journal-title":"Ann Surg Oncol."},{"key":"2932_CR25","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2217\/fon.09.129","volume":"5","author":"V Vinh-Hung","year":"2009","unstructured":"Vinh-Hung V, Nguyen NP, Cserni G, Truong P, Woodward W, Verkooijen HM, et al. Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol. 2009;5:1585\u2013603.","journal-title":"Future Oncol."},{"key":"2932_CR26","first-page":"19","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29:19\u201324.","journal-title":"Cell Oncol."},{"key":"2932_CR27","volume-title":"TNM Atlas","year":"2004","unstructured":"Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH, eds. TNM Atlas. 5th ed. Berlin: Springer-Verlag; 2004.","edition":"5"},{"key":"2932_CR28","volume-title":"International Classification of Diseases for Oncology","author":"A Fritz","year":"2000","unstructured":"Fritz A, Percy C, Jack A, Shanmugarathnam K, Sobin L, Parkin DM, et al. International Classification of Diseases for Oncology. 3rd edition. Geneva: World Health Organization; 2000.","edition":"3"},{"key":"2932_CR29","volume-title":"TNM Atlas","year":"1997","unstructured":"Hermanek P, Hutter RV, Sobin LH, eds. TNM Atlas. 4th ed. Berlin: Springer-Verlag; 1997.","edition":"4"},{"key":"2932_CR30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/bjc.1993.464","volume":"68","author":"LJ Schouten","year":"1993","unstructured":"Schouten LJ, Jager JJ, van den Brandt PA. Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer. 1993;68:974\u20137.","journal-title":"Br J Cancer."},{"key":"2932_CR31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejso.2006.02.012","volume":"32","author":"AY Kanter de","year":"2006","unstructured":"de Kanter AY, Menke-Pluijmers MB, Henzen-Logmans SC, van Geel AN, van Eijck CJ, Wiggers T, et al. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement. Eur J Surg Oncol. 2006;32:498\u2013501.","journal-title":"Eur J Surg Oncol."},{"key":"2932_CR32","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1200\/JCO.2001.19.6.1688","volume":"19","author":"AC Voogd","year":"2001","unstructured":"Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19:1688\u201397.","journal-title":"J Clin Oncol."},{"key":"2932_CR33","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.ijrobp.2005.05.044","volume":"63","author":"EA Strom","year":"2005","unstructured":"Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, et al. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:1508\u201313.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2932_CR34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jamcollsurg.2011.04.024","volume":"213","author":"SC Schiffman","year":"2011","unstructured":"Schiffman SC, McMasters KM, Scoggins CR, Martin RC, Chagpar AB. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. J Am Coll Surg. 2011;213:45\u201352.","journal-title":"J Am Coll Surg."},{"key":"2932_CR35","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/1097-0142(19920515)69:10<2496::AID-CNCR2820691018>3.0.CO;2-T","volume":"69","author":"CI Kiricuta","year":"1992","unstructured":"Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer. 1992;69:2496\u2013501.","journal-title":"Cancer."},{"key":"2932_CR36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jso.20061","volume":"87","author":"M Schaapveld","year":"2004","unstructured":"Schaapveld M, Otter R, de Vries EG, Fidler V, Grond JA, van der Graaf WT, et al. Variability in axillary lymph node dissection for breast cancer. J Surg Oncol. 2004;87:4\u201312.","journal-title":"J Surg Oncol."},{"key":"2932_CR37","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703\u201320.","journal-title":"J Clin Oncol."},{"key":"2932_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10434-999-0109-1","volume":"6","author":"RK Orr","year":"1999","unstructured":"Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival\u2014a Bayesian meta-analysis. Ann Surg Oncol. 1999;6:109\u201316.","journal-title":"Ann Surg Oncol."},{"key":"2932_CR39","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1245\/ASO.2003.03.073","volume":"10","author":"DN Krag","year":"2003","unstructured":"Krag DN, Single RM. Breast cancer survival according to number of nodes removed. Ann Surg Oncol. 2003;10:1152\u20139.","journal-title":"Ann Surg Oncol."},{"key":"2932_CR40","unstructured":"Dutch Institute for Clinical Auditing (2011). Dutch Breast Cancer Audit. Available at: http:\/\/www.clinicalaudit.nl\/images\/documenten\/2012\/jaarrapportage%202011.pdf . Accessed December 12, 2012."},{"key":"2932_CR41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1245\/s10434-010-1269-8","volume":"18","author":"MA Elferink","year":"2011","unstructured":"Elferink MA, Siesling S, Lemmens VE, Visser O, Rutten HJ, van Krieken JH, et al. Variation in lymph node evaluation in rectal cancer: a Dutch nationwide population-based study. Ann Surg Oncol. 2011;18:386\u201395.","journal-title":"Ann Surg Oncol."},{"key":"2932_CR42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdq312","volume":"22","author":"MA Elferink","year":"2011","unstructured":"Elferink MA, Siesling S, Visser O, Rutten HJ, van Krieken JH, Tollenaar RA, et al. Large variation between hospitals and pathology laboratories in lymph node evaluation in colon cancer and its impact on survival, a nationwide population-based study in the Netherlands. Ann Oncol. 2011;22:110\u20137.","journal-title":"Ann Oncol."},{"key":"2932_CR43","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2007.14.5565","volume":"26","author":"M Kyndi","year":"2008","unstructured":"Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419\u201326.","journal-title":"J Clin Oncol."},{"key":"2932_CR44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426\u201332.","journal-title":"Ann Surg."},{"key":"2932_CR45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569\u201375.","journal-title":"JAMA."},{"key":"2932_CR46","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1245\/s10434-012-2490-4","volume":"19","author":"CM Francissen","year":"2012","unstructured":"Francissen CM, Dings PJ, van Dalen T, Strobbe LJ, van Laarhoven HW, de Wilt JH. Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature. Ann Surg Oncol. 2012;19:4140\u20139.","journal-title":"Ann Surg Oncol."},{"key":"2932_CR47","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn HJ. Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736\u201347.","journal-title":"Ann Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-2932-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-013-2932-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-2932-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T13:53:10Z","timestamp":1644673990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-013-2932-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2932"],"URL":"https:\/\/doi.org\/10.1245\/s10434-013-2932-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}